TempraMed Technologies (FRA:9DY) Total Liabilities: €2.79 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:9DY TempraMed Technologies Ltd FRA:9DY
12 GF Score
Price €0.30
! 5 Warning Signs
View Full Analysis

What is TempraMed Technologies Total Liabilities?

TempraMed Technologies FRA:9DY -5.90% 12 Total Liabilities is €2.79 Mil as of Mar. 2026. GuruFocus rates FRA:9DY with a GF Score™ of 12/100. The stock has 5 warning signs investors should review.

TempraMed Technologies's Total Liabilities for the quarter that ended in Mar. 2026 was €2.79 Mil.

TempraMed Technologies's quarterly Total Liabilities declined from Sep. 2025 (€3.33 Mil) to Dec. 2025 (€3.18 Mil) and declined from Dec. 2025 (€3.18 Mil) to Mar. 2026 (€2.79 Mil).

TempraMed Technologies's annual Total Liabilities increased from Dec. 2023 (€0.00 Mil) to Dec. 2024 (€4.08 Mil) but then declined from Dec. 2024 (€4.08 Mil) to Dec. 2025 (€3.18 Mil).

TempraMed Technologies Total Liabilities Historical Data

* Premium members only.

The historical data trend for TempraMed Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TempraMed Technologies Total Liabilities Chart

TempraMed Technologies Annual Data
Trend Dec23 Dec24 Dec25
Total Liabilities
0.00 4.08 3.18

TempraMed Technologies Quarterly Data
Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only 0.00 4.13 3.33 3.18 2.79
FRA:9DY
12GF Score
TempraMed Technologies Ltd FRA:9DY
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TempraMed Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

TempraMed Technologies's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.565+(0.39+0.22
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=3.18

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1.573--1.602
=3.18

TempraMed Technologies's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.113+(0.418+0.259
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.79

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=1.254--1.536
=2.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €2.79 Mil mean?
TempraMed Technologies (FRA:9DY) has a Total Liabilities of €2.79 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for TempraMed Technologies and its competitors.
Is TempraMed Technologies' Total Liabilities too high?
TempraMed Technologies' current Total Liabilities is €2.79 Mil. Overall, TempraMed Technologies has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does TempraMed Technologies' Total Liabilities compare to ABT and SYK?
TempraMed Technologies' Total Liabilities of €2.79 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for TempraMed Technologies and its competitors. TempraMed Technologies's current Total Liabilities is €2.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TempraMed Technologies stock overvalued right now?
TempraMed Technologies (FRA:9DY) has a current Total Liabilities of €2.79 Mil. The current Total Liabilities is €2.79 Mil. TempraMed Technologies' overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For TempraMed Technologies (FRA:9DY), the current Total Liabilities is €2.79 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TempraMed Technologies Business Description

Other Exchanges VIVI:Canada
Address Heh B’Iyar 14, Tel-Aviv, ISR, 6209307
TempraMed Technologies Ltd through its subsidiary, engaged in developing patent-protected technology designed to serve a broad range of medical and consumer products. TempraMed's primary focus is revolutionizing storage and management of injectable for temperature-sensitive medications. This inventive technology ensures adequate temperature storage conditions to medications without requiring power source or human intervention for years.
12GF Score

Get the complete analysis for FRA:9DY

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.30
Price